関連する実験動画

Updated: May 1, 2026

Magnetic Adjustment of Afterload in Engineered Heart Tissues

Magnetic Adjustment of Afterload in Engineered Heart Tissues

Published on: May 5, 2020

CD4+T細胞は,慢性的な圧力過負荷の間に高縮から心不全への移行を促進します

Fanny Laroumanie¹, Victorine Douin-Echinard¹, Joffrey Pozzo¹

¹From the Institut National de la Santé et de la Recherche Médicale UMR1048 (INSERM), Institute of Cardiovascular and Metabolic Diseases (I2MC), Rangueil, Toulouse, France (F.L., V.D.-E., C.V., F.T., M.D., A.P., N.P.); Toulouse III University, Toulouse, France (F.L., V.D.-E., C.V., F.T., M.D., A.P., N.P.); Department of Cardiology, University Hospital of Rangueil, Toulouse, France (J.P., O.L.); and INSERM-UMS 006-Microsurgery Facility, Toulouse, France (C.D., D.C.).

|March 25, 2014

まとめ

CD4 ((+) T細胞と特異抗原認識は,補償性心筋縮が心不全 (HF) に進行する際に極めて重要です. これらのT細胞をブロックすると,HFの発症とマウスモデルにおける有害な心臓再構成が防止されます.

科学分野:

免疫学免疫学とは
心臓病学心臓病学
分子生物学は分子生物学である.

背景:

心不全 (HF) に繋がる慢性的な圧力過負荷に対する心臓の適応のメカニズムは不明である.
HFの進行におけるT細胞の関与は調査中です.
横動脈収縮 (TAC) は,圧力過負荷による心臓変化を研究するためのモデルです.

研究の目的:

T細胞が心筋縮からHFに進行する過程におけるT細胞の役割を調査する.
HFの病原化に関与する特定のT細胞サブセットを決定する.
HFの発達における抗原認識の重要性を探求する.

主な方法:

圧力過負荷を誘導するために,横動脈収縮 (TAC) のマウスモデルを使用しました.
TおよびBリンパ球 (RAG2KO),CD4(+) T細胞 (MHCIIKO),およびCD8(+) T細胞 (CD8KO) を欠いた遺伝子組み換えマウスを使用した.
評価された心機能,拡張,線維症,およびTAC後のコラーゲンリモデリング.

主要な成果:

慢性HFはTリンパ球を示し,心臓組織にCD4 (((+) T細胞の蓄積を活性化しました.
RAG2KOマウスは,TAC誘発の心臓の拡張と機能障害に対する抵抗を示した.
CD4 ((+)) T細胞 (MHCIIKO) が欠けていたマウスは,CD8KOマウスとは異なり,HF発症から保護された.
トランスジェニックのCD4 (((+) T細胞は,オバルブミンに特異的なHFと有害な改造を防止しました.

結論:

CD4 ((+) T細胞は,補償性高縮から心不全への移行において重要な役割を果たします.
CD4 ((+)) T細胞による特定の抗原の認識は,HFの進行に不可欠です.
CD4 ((+) T細胞の活性化または特定の抗原をターゲットにすることが,HFの治療戦略を提供することがあります.

キーワード:

心不全は,心不全を意味する.リンパ球はリンパ球の細胞である.室内リモジリング

さらに関連する動画

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

A Modified Technique for Transverse Aortic Constriction in Mice

A Modified Technique for Transverse Aortic Constriction in Mice

Published on: August 18, 2022

関連する概念動画

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Cellular Adaptation II: Hypertrophy

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Imbalances in Cardiac Output

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

Heart Failure I: Introduction

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...